Over the last 3 decades there have been substantial improvements in treatments aimed at
reducing cardiovascular (CV) events. As these treatments have been developed, there have …

As a research hotspot, the development of magnetic resonance imaging (MRI) contrast
agents has attracted great attention over the past decades for improving the accuracy of …

Recent advances in the synthesis of nanomaterials with diagnostic and therapeutic
capabilities have been rapidly resha** the landscape of precision medicine. Impressive …

Atherosclerosis (AS) is the formation of plaques in blood vessels, which leads to serious
cardiovascular diseases. Current research has disclosed that the formation of AS plaques is …

The inflammatory microenvironment involves changes in pH and protein phosphorylation
state and is closely related to the occurrence and development of atherosclerosis (AS) …

Chronic diseases claim millions of lives every year, and it is of great significance to explore
and develop advanced drugs to improve the cure rate of chronic diseases. Nanotheranostics …

Atherosclerosis is a chronic inflammatory disease involved in plaque rupture, stroke,
thrombosis, and heart attack (myocardial infarction), which is a leading cause of sudden …

Second near infrared (NIR‐II, 1000–1700 nm) fluorescence lifetime imaging is a powerful
tool for biosensing, anti‐counterfeiting, and multiplex imaging. However, the low …

Atherosclerosis (AS), a pathological cause of cardiovascular disease, results from
endothelial injury, local progressive inflammation, and excessive lipid accumulation. AS …

Despite the emergence of novel diagnostic, pharmacological, interventional, and prevention
strategies, atherosclerotic cardiovascular disease remains a significant cause of morbidity …